ADDEX THERAPEUTICS LTD (ADXN) Stock Balance Sheet
NASDAQ:ADXN - Nasdaq - US00654J2069 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.34M | N/A | N/A | N/A | 18.70M | |||
| Cash Equivalents | N/A | 3.87M | 6.96M | 20.48M | 18.70M | |||
| Receivables | 15.50K | 151.30K | 598.30K | 324.40K | 68.40K | |||
| Other Current Assets | 184.10K | 217.90K | 273.60K | 1.13M | 726.20K | |||
| Total Current Assets | 3.54M | 4.23M | 7.83M | 21.94M | 19.49M | |||
| Non-Current Assets | ||||||||
| PPE Net | 42.70K | 352.90K | 398.70K | 542.10K | 633.10K | |||
| Investments And Advances | 7.09M | N/A | N/A | N/A | N/A | |||
| Intangibles | 0.00 | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 7.10K | 54.30K | 54.40K | 57.90K | 59.10K | |||
| Total Non-Current Assets | 7.14M | 407.30K | 453.10K | 600.00K | 692.20K | |||
| TOTAL ASSETS | 10.68M | 4.64M | 8.28M | 22.54M | 20.18M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 7.30K | 274.00K | 286.10K | 287.70K | 308.60K | |||
| Accrued Expenses | 541.50K | 1.40M | 1.72M | 2.06M | 1.51M | |||
| Accounts Payable | 253.30K | 984.40K | 1.28M | 1.79M | 983.60K | |||
| Other Current Liabilities | 0.00 | 235.00K | N/A | 0.00 | 820.20K | |||
| Total Current Liabilities | 802.10K | 2.89M | 3.28M | 4.13M | 3.62M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 34.70K | 70.40K | 87.00K | 194.30K | 258.80K | |||
| Other Non-Current Liabilities | 164.30K | 532.80K | 0.00 | 1.28M | 1.69M | |||
| Total Non-Current Liabilities | 198.90K | 603.10K | 87.00K | 1.48M | 1.95M | |||
| TOTAL LIABILITIES | 1.00M | 3.50M | 3.37M | 5.61M | 5.57M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -323.17M | -331.51M | -330.37M | -316.32M | -305.13M | |||
| Additional Paid In Capital | 266.38M | 266.19M | 269.51M | 283.98M | 286.89M | |||
| Common Shares | 1.84M | 1.84M | 1.15M | 49.27M | 32.85M | |||
| Other Shareholders' Equity | 64.62M | 64.62M | 64.62M | N/A | N/A | |||
| Shares Outstanding | 1.07M | 1.04M | 838.45K | 411.95K | 294.78K | |||
| Tangible Book Value per Share | 0.10 | 0.01 | 0.06 | 0.45 | 0.54 | |||
| Total Shareholders' Equity | 9.68M | 1.15M | 4.91M | 16.93M | 14.61M | |||
| TOTAL LIABILITIES AND EQUITY | 10.68M | 4.64M | 8.28M | 22.54M | 20.18M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.06 | 0.02 | 0.01 | 0.02 | |||
| Current Ratio | 4.42 | 1.46 | 2.39 | 5.31 | 5.38 | |||
| Return On Assets (ROA) | 66.08% | -227.41% | -251.19% | -67.42% | -63.71% | |||
| Return On Equity (ROE) | 72.91% | -921.54% | -423.46% | -89.76% | -88.01% | |||
All data in CHF , ROIC based on taxRate of 0.21